{"id":24836,"date":"2024-11-20T11:38:19","date_gmt":"2024-11-20T10:38:19","guid":{"rendered":"https:\/\/idibell.cat\/en\/?p=24836"},"modified":"2024-11-20T12:08:05","modified_gmt":"2024-11-20T11:08:05","slug":"admit-therapeutics-receives-accreditation-from-college-of-american-pathologists","status":"publish","type":"post","link":"https:\/\/idibell.cat\/en\/2024\/11\/admit-therapeutics-receives-accreditation-from-college-of-american-pathologists\/","title":{"rendered":"Admit therapeutics receives accreditation from college of american pathologists"},"content":{"rendered":"
The Accreditation Committee of the College of American Pathologists (CAP) has awarded
\naccreditation to ADmit Therapeutics, Barcelona, Spain based on results of a recent on-site
\ninspection as part of the CAP\u2019s Accreditation Programs. Recognized for rigorous and robust
\nstandards, CAP accreditation elevates quality and mitigates risk, an important way that
\nlaboratories can contribute to improved patient outcomes.\u00a0ADmit Therapeutics is a
\nbiotechnology company founded at the end of 2017 as a spin-off from the Bellvitge Biomedical
\nResearch Institute (IDIBELL). The company is focused on the development and
\ncommercialization of a new early detection technology for Alzheimer\u2019s disease<\/p>\n
ADmit Therapeutics is one of more than 8,000 CAP-accredited facilities worldwide.\u00a0\u00a0The
\nfacility\u2019s director, Marta Blanch, PhD, was advised of this global recognition and congratulated
\nfor the excellence of the services being provided. \u201cBy obtaining CAP accreditation, we
\nguarantee that our laboratory meets the highest global standards for quality. This achievement
\nnot only validates our commitment to advancing scientific research, but also ensures the
\nreliability and accuracy of our services in the prognosis of progression from Mild Cognitive
\nImpairment to Alzheimer\u2019s Disease Dementia\u201d said Dr. Marta Blanch.<\/p>\n
Dr. Marta Barrachina, CEO of the company, upon learning of the laboratory\u2019s accreditation,
\nsaid: \u201cThis accreditation verifies the accuracy and reliability of our entire testing process and
\ndemonstrates the huge effort done by our team. I would like to highlight the excellent work of
\nour Quality Manager, Victor Fuentes, and our Laboratory Director, Dr. Marta Blanch.
\nMoreover, we are very proud of becoming the first CAP-accredited laboratory in Spain\u201d.<\/p>\n
During the CAP accreditation process, designed to ensure the highest standard of care for all
\nlaboratory patients, inspectors examine the laboratory\u2019s records and quality control of
\nprocedures. CAP inspectors also examine laboratory staff qualifications, equipment, facilities,
\nsafety program and record, and overall management. These reviews help verify activities and
\nreflect the most recent best practices.<\/p>\n
With over 23,000 laboratory participants, in addition to accreditation, the CAP offers
\nproficiency testing\/external quality assessment (PT\/EQA) programs, quality improvement
\ntools, and protocols and guidelines to ensure excellence in all areas across the laboratory. Built
\non a foundation of pathologist expertise, the College of American Pathologists (CAP) partners
\nwith laboratories worldwide to elevate the quality of laboratory medicine with best-in-class
\nsolutions designed to drive operational excellence, achieve diagnostic confidence, and ensure
\nthe best patient care.<\/p>\n
<\/p>\n
The Bellvitge Biomedical Research Institute (IDIBELL) is a biomedical research center created in 2004. It is participated by the Bellvitge University Hospital and the Viladecans Hospital of the Catalan Institute of Health, the Catalan Institute of Oncology, the University of Barcelona and the City Council of L\u2019Hospitalet de Llobregat.<\/em><\/p>\n IDIBELL is a member of the Campus of International Excellence of the University of Barcelona HUBc and is part of the CERCA institution of the Generalitat de Catalunya. In 2009 it became one of the first five Spanish research centers accredited as a health research institute by the Carlos III Health Institute. In addition, it is part of the \u201cHR Excellence in Research\u201d program of the European Union and is a member of EATRIS and REGIC. Since 2018, IDIBELL has been an Accredited Center of the AECC Scientific Foundation (FCAECC).<\/em><\/p>\n","protected":false},"excerpt":{"rendered":" The Accreditation Committee of the College of American Pathologists (CAP) has awarded accreditation to ADmit Therapeutics, Barcelona, Spain based on results of a recent on-site inspection as part of the CAP\u2019s Accreditation Programs. Recognized for rigorous and robust standards, CAP accreditation elevates quality and mitigates risk, an important way that laboratories can contribute to improved […]<\/p>\n","protected":false},"author":8,"featured_media":24837,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"default","adv-header-id-meta":"","stick-header-meta":"default","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"set","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"categories":[305],"tags":[],"class_list":["post-24836","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-innovation"],"publishpress_future_action":{"enabled":false,"date":"2024-12-29 03:18:59","action":"change-status","newStatus":"draft","terms":[],"taxonomy":"category"},"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"_links":{"self":[{"href":"https:\/\/idibell.cat\/en\/wp-json\/wp\/v2\/posts\/24836","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/idibell.cat\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/idibell.cat\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/idibell.cat\/en\/wp-json\/wp\/v2\/users\/8"}],"replies":[{"embeddable":true,"href":"https:\/\/idibell.cat\/en\/wp-json\/wp\/v2\/comments?post=24836"}],"version-history":[{"count":2,"href":"https:\/\/idibell.cat\/en\/wp-json\/wp\/v2\/posts\/24836\/revisions"}],"predecessor-version":[{"id":24839,"href":"https:\/\/idibell.cat\/en\/wp-json\/wp\/v2\/posts\/24836\/revisions\/24839"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/idibell.cat\/en\/wp-json\/wp\/v2\/media\/24837"}],"wp:attachment":[{"href":"https:\/\/idibell.cat\/en\/wp-json\/wp\/v2\/media?parent=24836"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/idibell.cat\/en\/wp-json\/wp\/v2\/categories?post=24836"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/idibell.cat\/en\/wp-json\/wp\/v2\/tags?post=24836"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}